{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:55:43Z","timestamp":1773370543599,"version":"3.50.1"},"reference-count":94,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"crossref","award":["QUCG-BRC-23\/24-125"],"award-info":[{"award-number":["QUCG-BRC-23\/24-125"]}],"id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"crossref","award":["QUST-1-BRC-2024-1696"],"award-info":[{"award-number":["QUST-1-BRC-2024-1696"]}],"id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"crossref","award":["QUST-1-BRC-2024-1697"],"award-info":[{"award-number":["QUST-1-BRC-2024-1697"]}],"id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"crossref","award":["QUST-1-BRC-2025-240"],"award-info":[{"award-number":["QUST-1-BRC-2025-240"]}],"id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"crossref","award":["QUST-1-BRC-2025-243"],"award-info":[{"award-number":["QUST-1-BRC-2025-243"]}],"id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"crossref","award":["QUCG-CHS-25\/26\u2013677"],"award-info":[{"award-number":["QUCG-CHS-25\/26\u2013677"]}],"id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"crossref","award":["1438"],"award-info":[{"award-number":["1438"]}],"id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"crossref"}]},{"name":"University of Aveiro and LAQV-REQUIMTE","award":["UID\/50006"],"award-info":[{"award-number":["UID\/50006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Plants"],"abstract":"<jats:p>Background: Chrysopogon zizanioides (L.) Roberty (vetiver) is a perennial medicinal grass with deep aromatic roots traditionally used for several ailments. Its root essential oil (CZEO) is rich in phytochemicals with documented antimicrobial, anti-inflammatory, and antioxidant activities. Although its anticancer potential remains underexplored, the complex phytochemical profile of CZEO positions it as a promising multi-target therapy, particularly for colorectal (CRC) and lung cancers where resistance and pathway redundancy often limit conventional treatments. Therefore, this study aimed to investigate the phytochemical composition and antiproliferative activity of CZEO from Qatar against colorectal (HCT-116) and lung (A549) cancer cells and to elucidate its molecular targets and mechanisms of action in CRC and lung cancer using network pharmacology and in silico approaches. Methods: CZEO was extracted by steam distillation and characterized using GC\u2013MS. In vitro proliferation assays with HCT-116 colorectal and A549 lung cancer cells were conducted using the Alamar Blue assay. The ten most abundant phytochemicals identified by GC\u2013MS were assessed for drug-likeness and ADMET properties and further analyzed through network pharmacology, molecular docking, and molecular dynamics (MD) simulations to elucidate the molecular targets and mechanisms underlying CZEO\u2019s anticancer activity. Results: GC-MS profiling identified 40 compounds, predominantly sesquiterpenoids (93%), including khusimol, \u03b2-eudesmol, \u03b1-vetivone, and rosifoliol. CZEO inhibited cancer cell viability in a dose-dependent manner, with IC50 values of 62.95 \u00b1 2.19 \u00b5g\/mL for HCT-116 and 167.82 \u00b1 6.51 \u00b5g\/mL for A549 cells, demonstrating greater potency against colorectal cancer. CZEO did not affect the growth of normal human neonatal fibroblasts (HDFn), suggesting potential selectivity for cancerous cells. ADMET predictions indicated favorable pharmacokinetics and low toxicity of CZEO\u2019s top 10 abundant compounds (TACs). Network pharmacology revealed 373 and 394 overlapping gene targets between TACs and lung and colorectal cancer, respectively. The overlapping genes were used to construct a protein\u2013protein interaction (PPI) network to identify hub genes. STAT3 and AKT1 consistently emerged as common top-scoring hub genes in both cancers. Molecular docking of TACs showed strong binding affinities of rosifoliol and \u03b1-vetivone to AKT1 (\u22126.20 and \u22125.93 kcal\/mol, respectively) and STAT3 (\u22125.19 and \u22125.09 kcal\/mol, respectively), surpassing reference inhibitors. MD simulations confirmed stable ligand\u2013protein interactions and structural stabilization, particularly with \u03b1-vetivone. Conclusions: CZEO from Qatar exhibits potent antiproliferative activity against colorectal and lung cancer cells, supported by a sesquiterpenoid-rich phytochemical profile. Integrative computational analyses highlight AKT1 and STAT3 as key molecular targets, with rosifoliol and \u03b1-vetivone emerging as promising lead compounds. These findings support CZEO as a natural, multi-target anticancer agent, warranting further mechanistic and in vitro and in vivo validation.<\/jats:p>","DOI":"10.3390\/plants15050784","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:17:31Z","timestamp":1772641051000},"page":"784","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chrysopogon zizanioides (Vetiver) Essential Oil from Qatar Targets AKT1 and STAT3 in Colorectal and Lung Cancer: GC-MS Profiling, In Vitro Antiproliferative Activity, and In Silico Analyses"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3563-7533","authenticated-orcid":false,"given":"Mai M.","family":"Karousa","sequence":"first","affiliation":[{"name":"Biomedical Research Center (BRC), QU Health, Qatar University, Doha P.O. Box 2713, Qatar"},{"name":"Biomedical Sciences Department, College of Health Sciences, QU Health, Qatar University, Doha P.O. Box 2713, Qatar"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5214-9087","authenticated-orcid":false,"given":"Haritha","family":"Kalath","sequence":"additional","affiliation":[{"name":"Biomedical Research Center (BRC), QU Health, Qatar University, Doha P.O. Box 2713, Qatar"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6970-0174","authenticated-orcid":false,"given":"Layal","family":"Karam","sequence":"additional","affiliation":[{"name":"Department of Nutrition Sciences, College of Health Sciences, QU Health, Qatar University, Doha P.O. Box 2713, Qatar"}]},{"given":"Muhammad","family":"Suleman","sequence":"additional","affiliation":[{"name":"Biomedical Research Center (BRC), QU Health, Qatar University, Doha P.O. Box 2713, Qatar"}]},{"given":"Maha M.","family":"Ayoub","sequence":"additional","affiliation":[{"name":"Biomedical Research Center (BRC), QU Health, Qatar University, Doha P.O. Box 2713, Qatar"},{"name":"Biomedical Sciences Department, College of Health Sciences, QU Health, Qatar University, Doha P.O. Box 2713, Qatar"}]},{"given":"Aseela","family":"Fathima","sequence":"additional","affiliation":[{"name":"Biomedical Research Center (BRC), QU Health, Qatar University, Doha P.O. Box 2713, Qatar"},{"name":"Biomedical Sciences Department, College of Health Sciences, QU Health, Qatar University, Doha P.O. Box 2713, Qatar"}]},{"given":"M. Angelica M.","family":"Rocha","sequence":"additional","affiliation":[{"name":"LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Campus de Santiago, 3810-193 Aveiro, Portugal"}]},{"given":"Samah","family":"Mechmechani","sequence":"additional","affiliation":[{"name":"Department of Nutrition Sciences, College of Health Sciences, QU Health, Qatar University, Doha P.O. Box 2713, Qatar"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4249-7089","authenticated-orcid":false,"given":"Diana C. G. A.","family":"Pinto","sequence":"additional","affiliation":[{"name":"LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Campus de Santiago, 3810-193 Aveiro, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7592-2788","authenticated-orcid":false,"given":"Hadi M.","family":"Yassine","sequence":"additional","affiliation":[{"name":"Biomedical Research Center (BRC), QU Health, Qatar University, Doha P.O. Box 2713, Qatar"},{"name":"Biomedical Sciences Department, College of Health Sciences, QU Health, Qatar University, Doha P.O. Box 2713, Qatar"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3524-7962","authenticated-orcid":false,"given":"Abdullah A.","family":"Shaito","sequence":"additional","affiliation":[{"name":"Biomedical Research Center (BRC), QU Health, Qatar University, Doha P.O. Box 2713, Qatar"},{"name":"Biomedical Sciences Department, College of Health Sciences, QU Health, Qatar University, Doha P.O. Box 2713, Qatar"},{"name":"College of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13045-024-01640-8","article-title":"Global burden of cancer and associated risk factors in 204 countries and territories, 1980\u20132021: A systematic analysis for the GBD 2021","volume":"17","author":"Wu","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"ref_2","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1056\/NEJMra0804588","article-title":"Molecular origins of cancer: Molecular basis of colorectal cancer","volume":"361","author":"Markowitz","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa0805019","article-title":"Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer","volume":"360","author":"Hitre","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrc.2016.126","article-title":"Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer","volume":"17","author":"Dienstmann","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12935-025-03734-w","article-title":"Intratumoral heterogeneity and drug resistance in cancer","volume":"25","author":"Fu","year":"2025","journal-title":"Cancer Cell Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12672-025-02198-8","article-title":"Advancements and limitations in traditional anti-cancer therapies: A comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy","volume":"16","author":"Zafar","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_10","first-page":"5794350","article-title":"Natural Products for Cancer Therapy: A Review of Their Mechanism of Actions and Toxicity in the Past Decade","volume":"2022","author":"Subramaniam","year":"2022","journal-title":"J. Trop. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"106957","DOI":"10.1016\/j.bioorg.2023.106957","article-title":"Discovery of plant-derived anti-tumor natural products: Potential leads for anti-tumor drug discovery","volume":"142","author":"Hui","year":"2024","journal-title":"Bioorg. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s11101-024-09940-0","article-title":"Recent advancements in natural compounds for cancer therapy and prevention","volume":"23","author":"Pavithra","year":"2024","journal-title":"Phytochem. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"de Sousa, D.P., Damasceno, R.O.S., Amorati, R., Elshabrawy, H.A., de Castro, R.D., Bezerra, D.P., Nunes, V.R.V., Gomes, R.C., and Lima, T.C. (2023). Essential Oils: Chemistry and Pharmacological Activities. Biomolecules, 13.","DOI":"10.3390\/biom13071144"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Sharifi-Rad, J., Sureda, A., Tenore, G.C., Daglia, M., Sharifi-Rad, M., Valussi, M., Tundis, R., Sharifi-Rad, M., Loizzo, M.R., and Ademiluyi, A.O. (2017). Biological Activities of Essential Oils: From Plant Chemoecology to Traditional Healing Systems. Molecules, 22.","DOI":"10.3390\/molecules22010070"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"112514","DOI":"10.1016\/j.biopha.2021.112514","article-title":"Essential oils as anticancer agents: Potential role in malignancies, drug delivery mechanisms, and immune system enhancement","volume":"146","author":"Sharma","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_16","unstructured":"Abate, H., and Simane, B. (2003). Multiple benefits of the vetiver system and its environmental application in ethiopia. Environ. Sci. Agric. Food Sci., 1\u201326."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"David, A., Wang, F., Sun, X., Li, H., Lin, J., Li, P., and Deng, G. (2019). Chemical Composition, Antioxidant, and Antimicrobial Activities of Vetiveria zizanioides (L.) Nash Essential Oil Extracted by Carbon Dioxide Expanded Ethanol. Molecules, 24.","DOI":"10.3390\/molecules24101897"},{"key":"ref_18","first-page":"777","article-title":"An Overview on Vetiveria zizanioides","volume":"2013","author":"Snigdha","year":"2023","journal-title":"Res. J. Pharm. Biol. Chem. Sci."},{"key":"ref_19","first-page":"191","article-title":"Traditional and Medicinal Uses of Vetiver","volume":"1","author":"Balasankar","year":"2013","journal-title":"J. Med. Plants Stud."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"44667","DOI":"10.1007\/s11356-021-15145-1","article-title":"Chrysopogon zizanioides\u2014A review on its pharmacognosy, chemical composition and pharmacological activities","volume":"28","author":"Grover","year":"2021","journal-title":"Environ. Sci. Pollut. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.foodchem.2012.02.131","article-title":"Study of the chemical composition, antioxidant activity and anti-inflammatory activity of essential oil from Vetiveria zizanioides","volume":"134","author":"Chou","year":"2012","journal-title":"Food Chem."},{"key":"ref_22","unstructured":"Credence, R. (2025, April 25). Vetiver Oil Market by Product Type (Organic, Conventional), By Application (Aromatherapy, Perfumery, Pharmaceuticals, Food & Beverages), By Region\u2014Growth, Share, Opportunities, Competitive Analysis, and Forecast 2024\u20132032. Available online: https:\/\/www.credenceresearch.com\/report\/vetiver-oil-market."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5666","DOI":"10.1002\/anie.202014609","article-title":"The Smelling Principle of Vetiver Oil, Unveiled by Chemical Synthesis","volume":"60","author":"Ouyang","year":"2021","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Burger, P., Landreau, A., Watson, M., Janci, L., Cassisa, V., Kempf, M., Azoulay, S., and Fernandez, X. (2017). Vetiver Essential Oil in Cosmetics: What Is New?. Medicines, 4.","DOI":"10.3390\/medicines4020041"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s11064-023-04032-5","article-title":"A Comprehensive Review of Essential Oils and Their Pharmacological Activities in Neurological Disorders: Exploring Neuroprotective Potential","volume":"49","author":"Qneibi","year":"2024","journal-title":"Neurochem. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1472-765X.2012.03216.x","article-title":"The additive and synergistic antimicrobial effects of select frankincense and myrrh oils\u2014A combination from the pharaonic pharmacopoeia","volume":"54","author":"Kamatou","year":"2012","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"15597","DOI":"10.1007\/s11356-021-12652-z","article-title":"Potential therapeutic effect of Chrysopogon zizanioides (Vetiver) as an anti-inflammatory agent","volume":"28","author":"Grover","year":"2021","journal-title":"Environ. Sci. Pollut. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.31557\/APJCP.2022.23.1.241","article-title":"Different Cytotoxic Effects of Vetiver Oil on Three Types of Cancer Cells, Mainly Targeting CNR2 on TNBC","volume":"23","author":"Hanifa","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_29","first-page":"591","article-title":"Anticancer activity of essential oils and their chemical components\u2014A review","volume":"4","author":"Bayala","year":"2014","journal-title":"Am. J. Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8288","DOI":"10.1158\/1078-0432.CCR-05-0827","article-title":"Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer","volume":"11","author":"Haura","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1034\/j.1600-0463.2002.11007811.x","article-title":"Non-small cell lung cancers frequently express phosphorylated Akt; an immunohistochemical study","volume":"110","author":"Lee","year":"2002","journal-title":"Apmis"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.18632\/oncotarget.6489","article-title":"Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis","volume":"7","author":"Franks","year":"2016","journal-title":"Oncotarget"},{"key":"ref_34","first-page":"5635","article-title":"High HIF-1\u03b1 expression predicts poor prognosis of patients with colon adenocarcinoma","volume":"11","author":"Huang","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/carcin\/bgt379","article-title":"Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3\/ERK manner","volume":"35","author":"Neradugomma","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref_36","first-page":"299","article-title":"Volatiles composition of fresh aroma and hydrodistilled volatile oil of Chrysopogon zizanioides roots growing in Egypt along with the cytotoxic activities of the hydrodistilled oil","volume":"67","author":"Arafat","year":"2024","journal-title":"Egypt. J. Chem."},{"key":"ref_37","first-page":"65","article-title":"Identification of Essential Oil Components by Gas Chromatography\/Quadrupole Mass Spectroscopy","volume":"16","author":"Adams","year":"2005","journal-title":"Carol. Stream"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Seglab, F., Abou Assali, M., AlYafei, T., Hassan, H., Pinto, D., Baydoun, S., Al Thani, A.A., and Shaito, A.A. (2024). Chemical Composition, Antioxidant Capacity, and Anticancerous Effects against Human Lung Cancer Cells of a Terpenoid-Rich Fraction of Inula viscosa. Biology, 13.","DOI":"10.20944\/preprints202407.0755.v1"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Shaito, A.A., Omairi, I., Al-Thani, N., Seglab, F., Ad-Darwish, E., Kobeissy, F., and Nasreddine, S. (2024). Determination of Medicago orbicularis Antioxidant, Antihemolytic, and Anti-Cancerous Activities and Its Augmentation of Cisplatin-Induced Cytotoxicity in A549 Lung Cancer Cells. Plants, 13.","DOI":"10.3390\/plants13030442"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Bramki, A., Barboucha, G., Benslama, O., Seglab, F., Makhlouf, F.Z., Nessah, S., Bensouici, C., Masi, M., and Shaito, A.A. (2025). Therapeutic Insights into Rubus ulmifolius Schott Leaf Extract: In Vitro Antifungal, Enzyme Inhibition, and Anticancer Activities Integrated with Network Pharmacology and Molecular Docking Analyses of Colorectal and Ovarian Cancer. Pharmaceuticals, 18.","DOI":"10.3390\/ph18101563"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Mesmar, J., Abdallah, R., Hamade, K., Baydoun, S., Al-Thani, N., Shaito, A., Maresca, M., Badran, A., and Baydoun, E. (2022). Ethanolic extract of Origanum syriacum L. leaves exhibits potent anti-breast cancer potential and robust antioxidant properties. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.994025"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2573183","DOI":"10.1080\/10942912.2025.2573183","article-title":"Nanoencapsulation mitigates the toxicity of thymol in human cells and zebrafish embryos","volume":"28","author":"Yammine","year":"2025","journal-title":"Int. J. Food Prop."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","article-title":"PubChem 2025 update","volume":"53","author":"Kim","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Chin, C.H., Chen, S.H., Wu, H.H., Ho, C.W., Ko, M.T., and Lin, C.Y. (2014). cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol., 8.","DOI":"10.1186\/1752-0509-8-S4-S11"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","article-title":"KEGG: Integrating viruses and cellular organisms","volume":"49","author":"Kanehisa","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: A graphical gene-set enrichment tool for animals and plants","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinformatics"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","article-title":"Pathview: An R\/Bioconductor package for pathway-based data integration and visualization","volume":"29","author":"Luo","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/wcms.1121","article-title":"An overview of the Amber biomolecular simulation package","volume":"3","author":"Case","year":"2013","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1063\/1.1324708","article-title":"Efficient particle-mesh Ewald based approach to fixed and induced dipolar interactions","volume":"113","author":"Toukmaji","year":"2000","journal-title":"J. Chem. Phys."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1021\/ct400314y","article-title":"Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald","volume":"9","author":"Gotz","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1006\/jmbi.1994.1017","article-title":"Significance of root-mean-square deviation in comparing three-dimensional structures of globular proteins","volume":"235","author":"Maiorov","year":"1994","journal-title":"J. Mol. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1073\/pnas.73.8.2740","article-title":"Thermodynamic fluctuations in protein molecules","volume":"73","author":"Cooper","year":"1976","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1134\/S0026893308040195","article-title":"Radius of gyration as an indicator of protein structure compactness","volume":"42","author":"Lobanov","year":"2008","journal-title":"Mol. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert. Opin. Drug Discov."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"ref_63","first-page":"251","article-title":"Chemical composition and biological properties of Chrysopogon zizanioides (L.) Roberty syn. Vetiveria zizanioides (L.) Nash\u2013A review","volume":"6","author":"Chahal","year":"2015","journal-title":"Indian J. Nat. Prod. Resour."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3906\/kim-2009-64","article-title":"GC-MS analyses and bioactivities of essential oil obtained from the roots of Chrysopogon zizanioides (L.) Roberty cultivated in Giresun, Turkey","volume":"45","author":"Efe","year":"2021","journal-title":"Turk. J. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.55416\/sunb.jns01.2201.08706","article-title":"Preliminary analysis on volatile composition of Chrysopogon zizanioides (L.) Roberty cultivated in Tunisia","volume":"87","author":"Romdhane","year":"2022","journal-title":"J. New Sci."},{"key":"ref_66","first-page":"223","article-title":"Constituents of south Indian vetiver oils","volume":"7","author":"Mallavarapu","year":"2012","journal-title":"Nat. Prod. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.22146\/ijc.21266","article-title":"Quality and Chemical Composition of Organic and Non-Organic Vetiver Oil","volume":"14","author":"Kadarohman","year":"2014","journal-title":"Indones. J. Chem."},{"key":"ref_68","unstructured":"Kotoky, R., Nath, S., Lekhak, H., Sarma, J., and Kalita, S. (2025, April 25). Seasonal Impact on Yield and Major Constituent of Essential Oil of Vetiveria zizanioides L. Nash Grown Under Jorhat Condition, Assam, India. Available online: https:\/\/www.vetiver.org\/ICV5\/Vetiver%20Oil\/4-4a%20Seasonal%20Impact%20On%20Yield%20And%20Major%20Constituent%20Of%20Essential%20Oil%20Of%20Vetiveria%20Zizanioides%20L.%20Nash%20Grown%20Under%20Jorhat%20Condition,%20Assam,%20India_.pdf."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3390\/11100817","article-title":"Highly volatile constituents of Vetiveria zizanioides roots grown under different cultivation conditions","volume":"11","author":"Pripdeevech","year":"2006","journal-title":"Molecules"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"104153","DOI":"10.1016\/j.tifs.2023.104153","article-title":"An overview of the chemical composition and bioactivities of Vetiveria zizanioides (L.) Nash essential oil","volume":"140","author":"David","year":"2023","journal-title":"Trends Food Sci. Technol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.22270\/jddt.v14i2.6299","article-title":"Exploring the Therapeutic Potential of Chrysopogon zizanioides Essential Oil: A Comprehensive Study on Its Chemical Composition, Thermal Analysis, and Biological Activities","volume":"14","author":"Jha","year":"2024","journal-title":"J. Drug Deliv. Ther."},{"key":"ref_72","first-page":"164","article-title":"Evaluation of anticancer activity of Vetiveria zizanioides against human breast cancer cell line","volume":"6","author":"Chitra","year":"2014","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Powers, C.N., Osier, J.L., McFeeters, R.L., Brazell, C.B., Olsen, E.L., Moriarity, D.M., Satyal, P., and Setzer, W.N. (2018). Antifungal and Cytotoxic Activities of Sixty Commercially-Available Essential Oils. Molecules, 23.","DOI":"10.3390\/molecules23071549"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Oliveira, T.A.S., Vieira, T.M., Esperandim, V.R., Martins, C.H.G., Magalh\u00e3es, L.G., Miranda, M.L.D., and Crotti, A.E.M. (2022). Antibacterial, Antiparasitic, and Cytotoxic Activities of Chemical Characterized Essential Oil of Chrysopogon zizanioides Roots. Pharmaceuticals, 15.","DOI":"10.3390\/ph15080967"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3109\/08923973.2011.558903","article-title":"Anti-inflammatory and antiulcerogenic activities of leaf extracts and sesquiterpene from Teucrium ramosissimum (Lamiaceae)","volume":"33","author":"Sghaier","year":"2011","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"ref_76","first-page":"1407","article-title":"Widdrol induces apoptosis via activation of AMP-activated protein kinase in colon cancer cells","volume":"27","author":"Kang","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/10286020701394332","article-title":"Beta-eudesmol suppresses tumour growth through inhibition of tumour neovascularisation and tumour cell proliferation","volume":"10","author":"Ma","year":"2008","journal-title":"J. Asian Nat. Prod. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"107529","DOI":"10.1016\/j.toxicon.2023.107529","article-title":"\u03b2-eudesmol inhibits cell proliferation and induces ferroptosis via regulating MAPK signaling pathway in breast cancer","volume":"237","author":"Li","year":"2024","journal-title":"Toxicon"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1039\/C8MD00472B","article-title":"ADMET-score\u2014A comprehensive scoring function for evaluation of chemical drug-likeness","volume":"10","author":"Guan","year":"2019","journal-title":"Medchemcomm"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"9569","DOI":"10.1038\/s41598-023-36687-z","article-title":"Use of network pharmacology and molecular docking to explore the mechanism of action of curcuma in the treatment of osteosarcoma","volume":"13","author":"Hu","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Wang, J., Zhang, Z., Li, Q., Hu, Z., Chen, Y., Chen, H., Cai, W., Du, Q., Zhang, P., and Xiong, D. (2024). Network pharmacology and molecular docking reveal the mechanisms of curcumin activity against esophageal squamous cell carcinoma. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1282361"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Batool, S., Javed, M.R., Aslam, S., Noor, F., Javed, H.M.F., Seemab, R., Rehman, A., Aslam, M.F., Paray, B.A., and Gulnaz, A. (2022). Network Pharmacology and Bioinformatics Approach Reveals the Multi-Target Pharmacological Mechanism of Fumaria indica in the Treatment of Liver Cancer. Pharmaceuticals, 15.","DOI":"10.3390\/ph15060654"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"15730","DOI":"10.1038\/s41598-020-72797-8","article-title":"Network pharmacology based virtual screening of active constituents of Prunella vulgaris L. and the molecular mechanism against breast cancer","volume":"10","author":"Zhang","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_84","first-page":"85","article-title":"The prolactin receptor: Diverse and emerging roles in pathophysiology","volume":"2","author":"Gorvin","year":"2015","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Lee, K., Choi, Y.J., Lim, H.I., Cho, K.J., Kang, N., and Ko, S.G. (2024). Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer. BMC Complement. Med. Ther., 24.","DOI":"10.1186\/s12906-024-04347-y"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nature11465","article-title":"Adenoma-linked barrier defects and microbial products drive IL-23\/IL-17-mediated tumour growth","volume":"491","author":"Grivennikov","year":"2012","journal-title":"Nature"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cyto.2018.12.021","article-title":"IL-17 and colorectal cancer: From carcinogenesis to treatment","volume":"116","author":"Razi","year":"2019","journal-title":"Cytokine"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1007\/s12013-025-01816-0","article-title":"The Significance of STAT3 in Colonic Diseases: A Comprehensive Study of Pathological Roles and Therapeutic Implications","volume":"83","author":"Ahmed","year":"2025","journal-title":"Cell Biochem. Biophys."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bcp.2014.05.011","article-title":"Targeting PI3K\/AKT\/mTOR pathway in non small cell lung cancer","volume":"90","author":"Fumarola","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Agarwal, E., Chaudhuri, A., Leiphrakpam, P.D., Haferbier, K.L., Brattain, M.G., and Chowdhury, S. (2014). Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-145"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.7150\/jca.14713","article-title":"AKT-STAT3 Pathway as a Downstream Target of EGFR Signaling to Regulate PD-L1 Expression on NSCLC cells","volume":"7","author":"Abdelhamed","year":"2016","journal-title":"J. Cancer"},{"key":"ref_92","first-page":"9655","article-title":"PI3K\/AKT inhibition induces compensatory activation of the MET\/STAT3 pathway in non-small cell lung cancer","volume":"15","author":"Bian","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13046-024-02958-4","article-title":"JAK\/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors","volume":"43","author":"Pennel","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ccell.2019.10.002","article-title":"A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo","volume":"36","author":"Bai","year":"2019","journal-title":"Cancer Cell"}],"container-title":["Plants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2223-7747\/15\/5\/784\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:47:06Z","timestamp":1773330426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2223-7747\/15\/5\/784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":94,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["plants15050784"],"URL":"https:\/\/doi.org\/10.3390\/plants15050784","relation":{},"ISSN":["2223-7747"],"issn-type":[{"value":"2223-7747","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]}}}